Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
BAYZF
BAYZF News & Events
-
Add to Watchlist
Trade BAYZF
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
News
BAYZF News
Bayer publishes findings on gadoquatrane contrast agent for pediatric use
Dec 03 2025
SeekingAlpha
Bayer Rises Following Trump Administration's Support for Supreme Court Review in Roundup Lawsuit
Dec 02 2025
SeekingAlpha
Bayer's Asundexian Achieves Key Efficacy and Safety Goals in Pivotal Phase III OCEANIC-STROKE Trial for Secondary Stroke Prevention
Nov 23 2025
Newsfilter
U.S. FDA Grants Approval for HYRNUO® (sevabertinib) in Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Who Have Previously Received Treatment
Nov 20 2025
Newsfilter
Bayer Remains Optimistic About Long-Term Prospects Despite Legal Challenges
Nov 12 2025
Benzinga
Bayer AG announces varied Q3 performance while maintaining FY25 forecast
Nov 12 2025
SeekingAlpha
Bayer Unveils "Science Delivers" Campaign Highlighting the Impact of Scientific Innovation
Nov 10 2025
Newsfilter
Bayer's Lynkuet® (elinzanetant) Becomes the First FDA-Approved Neurokinin 1 and 3 Receptor Antagonist for Treating Moderate to Severe Menopausal Hot Flashes
Oct 24 2025
Newsfilter
Show More News
BAYZF Events
No data
BAYZF Monitor News
No data
BAYZF Earnings Analysis
No Data
People Also Watch
